Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Receivables: 2019-2024

Historic Change in Receivables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$14.4 million.

  • Maravai Lifesciences Holdings' Change in Receivables rose 14.99% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 74.44%. This contributed to the annual value of -$14.4 million for FY2024, which is 82.99% up from last year.
  • Maravai Lifesciences Holdings' Change in Receivables amounted to -$14.4 million in FY2024, which was up 82.99% from -$84.4 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Receivables registered a high of $70.4 million during FY2021, and its lowest value of -$84.4 million during FY2023.
  • For the 3-year period, Maravai Lifesciences Holdings' Change in Receivables averaged around -$25.5 million, with its median value being -$14.4 million (2024).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Change in Receivables spiked by 1,655.51% in 2020, and later crashed by 478.93% in 2023.
  • Maravai Lifesciences Holdings' Change in Receivables (Yearly) stood at $33.1 million in 2020, then spiked by 112.38% to $70.4 million in 2021, then plummeted by 68.36% to $22.3 million in 2022, then plummeted by 478.93% to -$84.4 million in 2023, then surged by 82.99% to -$14.4 million in 2024.